Core Viewpoint - The company has released its 2024 ESG report, highlighting its initiatives and achievements in environmental, social, and governance areas, with a strong focus on green and low-carbon development [1] Group 1: Environmental Initiatives - The company has established a cross-departmental carbon management team and set clear greenhouse gas reduction targets, aiming to reduce Scope 1 and Scope 2 carbon emission intensity by 50% by 2035, using 2023 as the baseline [1] - In 2024, the company's greenhouse gas emissions amounted to 54,443.92 tons CO2e (Scope 1 and Scope 2, based on market), representing a 28% reduction (21,000 tons CO2e) compared to the 2023 baseline [1] - The greenhouse gas emission intensity decreased to 5.29 tons CO2e per million revenue, a year-on-year decline of 21%, with 41% of the mid-term goal of a 50% reduction by 2035 already achieved [1] Group 2: Technological Advancements - The company has launched the world's first silicon carbide MRI, which improves intelligent diagnostic efficiency by 30% and reduces equipment energy consumption by 57% [2] - The new generation PET/CT product utilizes more environmentally friendly materials and technologies to replace traditional lead shielding structures, effectively reducing environmental pollution [2] - The breast DR limiter innovatively uses steel instead of lead for X-ray limiting and shielding, achieving environmentally friendly and harmless solutions [2] - In the transportation segment, the company employs cold chain transportation technology for MRI equipment, significantly reducing liquid helium consumption, saving nearly 700,000 liters in 2024 [2]